Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan;50(1):57-8.
doi: 10.4103/0019-5545.39762.

Levofloxacin-induced acute psychosis

Affiliations

Levofloxacin-induced acute psychosis

Nagaraja Moorthy et al. Indian J Psychiatry. 2008 Jan.

Abstract

A wide range of drugs can cause mental status changes. Fluoroquinolones are one among them and are underrecognised.The CNS side effects of levofloxacin like headache, dizziness, restlessness, tremor, insomnia, hallucinations, convulsions, anxiety and depression are well documented. We report a rare case of middle aged diabetic male admitted to hospital with multiple infections who developed acute psychosis following levofloxacin administration.

Keywords: Acute psychosis; fluoroquinolones; levofloxacin.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Farrington J, Stoudemire A, Tierney J. The role of ciprofloxacin in a patient with delirium due to multiple etiologies. Gen Hosp Psychiatry. 1995;17:47–53. - PubMed
    1. Segev S, Rehavi M, Rubinstein E. Quinolones, theophylline and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother. 1988;32:1624–6. - PMC - PubMed
    1. Norrby SR, Petermann W. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand J Infect Dis. 1999;30:387–404. - PubMed
    1. Erden BF, Ulak G, Yildiz F, Utkan T, Ozdemirci S, Gacar N. Antidepressant, anxiogenic and antinociceptive properties of levofloxacin in rats and mice. Pharmacol Biochem Behav. 2001;68:435–41. - PubMed
    1. Ball P, Mandell L, Niki Y, Tillotson G. Comparative tolerability of newer fluoroquinolone antibacterials. Drug Saf. 1999;21:407–21. - PubMed